|
|
||||||||
From the Department of Neurology (Dr. Shefner), State University of New York Health Science Center at Syracuse, NY; Cephalon, Inc. (Drs. Reaume, Flood, and Scott), West Chester, PA; the Geriatric Research, Education and Clinical Center (Drs. Kowall, Ferrante, and Siwek), Bedford VA Medical Center, MA; and the Cecil B. Day Laboratory for Neuromuscular Research (Dr. Brown and M. UptonRice), Massachusetts General Hospital, Boston, MA.
Address correspondence and reprint requests to Dr. J.M. Shefner, Department of Neurology, SUNY Health Science Center, 750 East Adams Street, Syracuse, NY 13210; e-mail: Shefnerj{at}Vax.cs.hscsyr.edu
OBJECTIVE: To characterize the motor neuron dysfunction in two models by performing physiologic and morphometric studies.
BACKGROUND: Mutations in the gene encoding cytosolic superoxide dismutase 1 (SOD1) account for 25% of familial ALS (FALS). Transgenes with these mutations produce a pattern of lower motor neuron degeneration similar to that seen in patients with FALS. In contrast, mice lacking SOD1 develop subtle motor symptoms by approximately 6 months of age.
METHODS: Physiologic measurements, including motor conduction and motor unit estimation, were analyzed in normal mice, mice bearing the human transgene for FALS (mFALS mice), and knockout mice deficient in SOD1 (SOD1-KO). In addition, morphometric analysis was performed on the spinal cords of SOD1-KO and normal mice.
RESULTS: In mFALS mice, the motor unit number in the distal hind limb declined before behavioral abnormalities appeared, and motor unit size increased. Compound motor action potential amplitude and distal motor latency remained normal until later in the disease. In SOD1-KO mice, motor unit numbers were reduced early but declined slowly with age. In contrast with the mFALS mice, SOD1-KO mice demonstrated only a modest increase in motor unit size. Morphometric analysis of the spinal cords from normal and SOD1-KO mice showed no significant differences in the number and size of motor neurons.
CONCLUSIONS: The physiologic abnormalities in mFALS mice resemble those in human ALS. SOD1-deficient mice exhibit a qualitatively different pattern of motor unit remodeling that suggests that axonal sprouting and reinnervation of denervated muscle fibers are functionally impaired in the absence of SOD1.
Key words: ALSSOD1Motor unit estimation.
This article has been cited by other articles:
![]() |
J. Hegedus, C. T. Putman, N. Tyreman, and T. Gordon Preferential motor unit loss in the SOD1G93A transgenic mouse model of amyotrophic lateral sclerosis J. Physiol., July 15, 2008; 586(14): 3337 - 3351. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. L. Muller, W. Song, Y. C. Jang, Y. Liu, M. Sabia, A. Richardson, and H. Van Remmen Denervation-induced skeletal muscle atrophy is associated with increased mitochondrial ROS production Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R1159 - R1168. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sau, S. De Biasi, L. Vitellaro-Zuccarello, P. Riso, S. Guarnieri, M. Porrini, S. Simeoni, V. Crippa, E. Onesto, I. Palazzolo, et al. Mutation of SOD1 in ALS: a gain of a loss of function Hum. Mol. Genet., July 1, 2007; 16(13): 1604 - 1618. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Major, J. Hegedus, D. J. Weber, T. Gordon, and K. E. Jones Method for Counting Motor Units in Mice and Validation Using a Mathematical Model J Neurophysiol, February 1, 2007; 97(2): 1846 - 1856. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hadano, S. C. Benn, S. Kakuta, A. Otomo, K. Sudo, R. Kunita, K. Suzuki-Utsunomiya, H. Mizumura, J. M. Shefner, G. A. Cox, et al. Mice deficient in the Rab5 guanine nucleotide exchange factor ALS2/alsin exhibit age-dependent neurological deficits and altered endosome trafficking Hum. Mol. Genet., January 15, 2006; 15(2): 233 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tummala, C. Jung, A. Tiwari, C. M. J. Higgins, L. J. Hayward, and Z. Xu Inhibition of Chaperone Activity Is a Shared Property of Several Cu,Zn-Superoxide Dismutase Mutants That Cause Amyotrophic Lateral Sclerosis J. Biol. Chem., May 6, 2005; 280(18): 17725 - 17731. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Maxwell, P. Pasinelli, A. G. Kazantsev, and R. H. Brown Jr. RNA interference-mediated silencing of mutant superoxide dismutase rescues cyclosporin A-induced death in cultured neuroblastoma cells PNAS, March 2, 2004; 101(9): 3178 - 3183. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Valentine and P. J. Hart Bioinorganic Chemistry Special Feature: Misfolded CuZnSOD and amyotrophic lateral sclerosis PNAS, April 1, 2003; 100(7): 3617 - 3622. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Shefner, R. H. Brown Jr., D. Cole, P. Chaturvedi, D. Schoenfeld, K. Pastuszak, R. Matthews, M. Upton-Rice, and M. E. Cudkowicz Effect of neurophilin ligands on motor units in mice with SOD1 ALS mutations Neurology, November 27, 2001; 57(10): 1857 - 1861. [Abstract] [Full Text] [PDF] |
||||
![]() |
Copper, Zinc Superoxide Dismutase Sci. Aging Knowl. Environ., October 31, 2001; 2001(5): tg15 - 15. [Full Text] |
||||
![]() |
S. Hadjur, K. Ung, L. Wadsworth, J. Dimmick, E. Rajcan-Separovic, R. W. Scott, M. Buchwald, and F. R. Jirik Defective hematopoiesis and hepatic steatosis in mice with combined deficiencies of the genes encoding Fancc and Cu/Zn superoxide dismutase Blood, August 15, 2001; 98(4): 1003 - 1011. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |